Japan Lifeline Co., Ltd. (7575.T) JPX

Currency In JPY

AD

Japan Lifeline Co., Ltd.

Address

Tennoz Ocean Square

Tokyo, 140-0002

Japan

Phone

81 3 6711 5200

Sector

Healthcare

Industry

Medical - Devices

Employees

1216

First IPO Date

January 04, 2000

Key Executives

NameTitlePayYear Born
Keisuke SuzukiPresident, Chief Executive Officer & Representative Director01953
Yoshiaki IkeiIndependent Outside Director01957
Naohiro NakadaSenior Operating Officer & Deputy Head of Arrhythmia Business Operations Group0N/A
Tatsuya MuraseVice President, Chief Operating Officer & Representative Director01973
Toru TakamiyaSenior Executive Officer, Head of R&D and Production Group & Director01964
Toshihiro MiyakeExecutive Officer and General Manager of RA Division R & D & Production Group0N/A
Takeyoshi EgawaDirector, Executive Officer & Head of Corporate Management Group01976
KuNobuo TakahashiSenior Operating Officer & Head of Global Business Development Group0N/A
Yumiko HoshibaDirector, Senior Operating Officer & GM of Operations Division of Corporate Administration Group01962
Kenji YamadaDirector, Executive Officer & Head of Corporate Administration Group01971
Takashi ItoExecutive Officer, Head of Arrhythmia Business Operations Group & Director01968
AD

Description

Japan Lifeline Co., Ltd. is a medical technology firm based in Japan that specializes in cardiovascular healthcare devices. Its operations encompass research, manufacturing, global procurement, and sales of these specialized medical instruments within the country. The company's diverse product range includes solutions for cardiac rhythm management, such as pacemakers, implantable cardioverter defibrillators (including subcutaneous models), cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support tools. For electrophysiology and ablation procedures, Japan Lifeline offers various electrophysiological and ablation catheters (like irrigated tip versions), endoscopic balloon ablation systems, esophageal temperature monitors, internal atrial cardioversion systems, and radio-frequency transseptal needles. Furthermore, its portfolio extends to cardiovascular and endografting products, including vascular, open, and abdominal stent-grafts. In the transvascular intervention segment, the company provides PTCA and PTA guide wires, PTCA balloon catheters, radiofrequency wires, and devices for closing atrial septal defects. Complementing these, its gastrointestinal intervention solutions encompass radiofrequency ablation systems, self-expandable colonic stents, and endoscopic guidewires. Established in 1981, Japan Lifeline Co., Ltd. maintains its headquarters in Tokyo, Japan.

AD